Federal Awards · EXELAN PHARMACEUTICALS INC · Award

NEW AWARD FOR RAMIPRIL CAPSULES WITH EXELAN PHARMACEUTICALS INC. THE PERIOD OF PERFORMANCE IS MARCH 14, 202…

Award details are derived from public USAspending.gov records. Not a bid recommendation.

Award details

Award ID
36E79722D0010
Contractor
EXELAN PHARMACEUTICALS INC
Sub-agency / office
Department of Veterans Affairs
Award amount
$0
Period of performance
Mar 14, 2022 – —
NAICS
325412 — Pharmaceutical Preparation Manufacturing
PSC
PSC 6505
Competition
FULL AND OPEN COMPETITION · Set-aside: NO SET ASIDE USED. · 2 offers
Pricing
FIRM FIXED PRICE
Financial breakdown
Obligated $0 · Potential value $12,802,166 · Latest action obligation $0

Public award description

NEW AWARD FOR RAMIPRIL CAPSULES WITH EXELAN PHARMACEUTICALS INC. THE PERIOD OF PERFORMANCE IS MARCH 14, 2022 TO MARCH 13, 2023 WITH FOUR ONE-YEAR OPTIONS.

Most recent · Modification P00015 · Sep 2, 2026 · $0 action obligation · IMPLEMENTATION OF EXECUTIVE ORDER 14398 ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS · 36E79722D0010

Modification P00014 · Mar 18, 2026 · $0 action obligation · INCORPORATE THE 2026/2027 APPROVED SUBCONTRACTING PLAN · 36E79722D0010

Modification P00013 · Feb 12, 2026 · $0 action obligation · EXERCISE OPTION YEAR 4 WITH EXELAN PHARMACEUTICALS FOR RAMIPRIL CAPSULES. PERIOD OF PERFORMANCE IS MARCH 14, 2026 - MARCH 13, 2027 WITH NO PRICE CHANGES. · 36E79722D0010

Modification P00012 · Apr 11, 2025 · $0 action obligation · TO INCORPORATE THE 2025 APPROVED SUBCONTRACTING PLAN · 36E79722D0010

Modification P00011 · Feb 19, 2025 · $0 action obligation · EXERCISE OPTION YEAR THREE WITH EXELAN PHARMACEUTICALS FOR RAMIPRIL CAPSULES. PERIOD OF PERFORMANCE IS 3/14/2025 - 3/13/2026. NO PRICE CHANGES · 36E79722D0010

Modification P00010 · May 2, 2024 · $0 action obligation · TO INCORPORATE A CHANGE IN THE ADMINISTRATIVE AND SALES POINT OF CONTACT FOR EXELAN PHARMACEUTICALS, INC. · 36E79722D0010

Modification P00009 · Mar 26, 2024 · $0 action obligation · TO INCORPORATE THE 2024/2025 APPROVED SUBCONTRACTING PLAN · 36E79722D0010

Modification P00008 · Mar 18, 2024 · $0 action obligation · CHANGE TIMEFRAME FOR THE SUBMISSION OF QUARTERLY SALES REPORTS AND COST RECOVERY FEE TO 30 CALENDAR DAYS AFTER END OF EACH FISCAL QUARTER. · 36E79722D0010

Modification P00007 · Feb 5, 2024 · $0 action obligation · EXERCISE OPTION YEAR TWO FOR RAMIPRIL CAPSULES. PERIOD OF PERFORMANCE IS 3/14/2024 THROUGH 3/13/2025. · 36E79722D0010

Modification P00006 · Jan 30, 2024 · $0 action obligation · TO INCORPORATE A CHANGE IN THE ADMINISTRATIVE AND SALES POINT OF CONTACT FOR EXELAN PHARMACEUTICALS INC. · 36E79722D0010

Modification P00005 · Sep 28, 2023 · $0 action obligation · TO INCORPORATE A CHANGE IN THE ADMINISTRATIVE AND SALES POINT OF CONTACT FOR EXELAN PHARMACEUTICALS INC. · 36E79722D0010

Modification P00004 · Jun 15, 2023 · $0 action obligation · INCORPORATION OF DRUG SUPPLY CHAIN SECURITY ACT (DSCSA) LANGUAGE · 36E79722D0010

Modification P00003 · Apr 12, 2023 · $0 action obligation · INCORPORATE 2023 SMALL BUSINESS SUBCONTRACTING PLAN INTO CONTRACT. PLAN IS EFFECTIVE 4/1/2023 - 3/31/2024. · 36E79722D0010

Modification P00002 · Mar 3, 2023 · $0 action obligation · EXERCISE OPTION YEAR 1 EFFECTIVE MARCH 14, 2023 TO MARCH 13, 2024 FOR RAMIPRIL CAPSULES WITH EXELAN PHARMACEUTICALS, INC. · 36E79722D0010

Modification P00001 · Feb 24, 2022 · $0 action obligation · INCORPORATE THE 2022 APPROVED SUBK PLAN. PLAN EFFECTIVE 4/1/2022 - 3/31/2023. · 36E79722D0010

Modification 0 · Jan 13, 2022 · $0 action obligation · NEW AWARD FOR RAMIPRIL CAPSULES WITH EXELAN PHARMACEUTICALS INC. THE PERIOD OF PERFORMANCE IS MARCH 14, 2022 TO MARCH 13, 2023 WITH FOUR ONE-YEAR OPTIONS. · 36E79722D0010

Source: USAspending.gov

Related intelligence

Related Federal Awards

  • Same agency and NAICS · 36C24026K1010 — EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JULY · MCKESSON CORPORATION · Department of Veterans Affairs · $1,194,619,137
  • Same agency and NAICS · 36C25926F0310 — EMERGENCY PHARMACY CARVYKTI FOR RMR · JANSSEN BIOTECH INC · Department of Veterans Affairs · $384,719
  • Same agency and NAICS · 36C26226N0738 — Federal award — Department of Veterans Affairs · BRISTOL-MYERS SQUIBB COMPANY · Department of Veterans Affairs · $364,139
  • Same agency and NAICS · 36C24626P0824 — OMINCELL IVX WORKFLOW MANAGEMENT (4 DEVICES), IVX LABEL SFW, IVX COLOR PRINTER, IVX ZEBRA BARCODE SCANNER, · TRILLAMED LLC · Department of Veterans Affairs · $268,200
  • Same agency and NAICS · 36C77026N0048 — Federal award — Department of Veterans Affairs · MERZ PHARMACEUTICALS, LLC · Department of Veterans Affairs · $236,612
  • Same agency and NAICS · 36C24626N1034 — Federal award — Department of Veterans Affairs · PARTNER THERAPEUTICS, INC. · Department of Veterans Affairs · $72,362

Browse federal awards · Browse contractors

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

SmartSoloChatGPTClaudePerplexityGrokGemini

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.